Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevi.
Calbet-Llopart N, Pascini-Garrigos M, Tell-Martí G, Potrony M, Martins da Silva V, Barreiro A, Puig S, Captier G, James I, Degardin N, Carrera C, Malvehy J, Etchevers HC, Puig-Butillé JA. Calbet-Llopart N, et al. Among authors: tell marti g. Pigment Cell Melanoma Res. 2020 Sep;33(5):685-694. doi: 10.1111/pcmr.12883. Epub 2020 May 20. Pigment Cell Melanoma Res. 2020. PMID: 32323445 Free article.
Influence of germline genetic variants on dermoscopic features of melanoma.
Pozzobon FC, Tell-Marti G, Calbet-Llopart N, Barreiro A, Espinosa N, Potrony M, Alejo B, Podlipnik S, Combalia M, Puig-Butillé JA, Carrera C, Malvehy J, Puig S. Pozzobon FC, et al. Among authors: tell marti g. Pigment Cell Melanoma Res. 2021 May;34(3):618-628. doi: 10.1111/pcmr.12954. Epub 2021 Jan 31. Pigment Cell Melanoma Res. 2021. PMID: 33342058
AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy.
Puig-Butille JA, Vinyals A, Ferreres JR, Aguilera P, Cabré E, Tell-Martí G, Marcoval J, Mateo F, Palomero L, Badenas C, Piulats JM, Malvehy J, Pujana MA, Puig S, Fabra À. Puig-Butille JA, et al. J Invest Dermatol. 2017 Jun;137(6):1297-1310. doi: 10.1016/j.jid.2017.01.021. Epub 2017 Feb 7. J Invest Dermatol. 2017. PMID: 28188776 Free article.
Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations.
Martins da Silva V, Martinez-Barrios E, Tell-Martí G, Dabad M, Carrera C, Aguilera P, Brualla D, Esteve-Codina A, Vicente A, Puig S, Puig-Butillé JA, Malvehy J. Martins da Silva V, et al. J Invest Dermatol. 2019 Apr;139(4):900-908. doi: 10.1016/j.jid.2018.07.045. Epub 2018 Oct 22. J Invest Dermatol. 2019. PMID: 30359577 Free article.
Mutational status of naevus-associated melanomas.
Shitara D, Tell-Martí G, Badenas C, Enokihara MM, Alós L, Larque AB, Michalany N, Puig-Butille JA, Carrera C, Malvehy J, Puig S, Bagatin E. Shitara D, et al. Br J Dermatol. 2015 Sep;173(3):671-80. doi: 10.1111/bjd.13829. Epub 2015 Jun 19. Br J Dermatol. 2015. PMID: 25857817 Free PMC article.
Detection of cell-free circulating BRAFV 600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance.
Calbet-Llopart N, Potrony M, Tell-Martí G, Carrera C, Barreiro A, Aguilera P, Podlipnik S, Puig S, Malvehy J, Puig-Butillé JA. Calbet-Llopart N, et al. Among authors: tell marti g. Br J Dermatol. 2020 Feb;182(2):382-389. doi: 10.1111/bjd.18147. Epub 2019 Aug 12. Br J Dermatol. 2020. PMID: 31102256
Clinical utility of liquid biopsy for monitoring patients with NRAS-mutant medium-to-giant congenital melanocytic nevi.
Calbet-Llopart N, Tell-Martí G, Mateu J, Feito M, Martínez S, Puig S, Malvehy J, Carrera C, Puig-Butillé JA. Calbet-Llopart N, et al. Among authors: tell marti g. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e200-e203. doi: 10.1111/jdv.18584. Epub 2022 Oct 13. J Eur Acad Dermatol Venereol. 2023. PMID: 36151998 No abstract available.
36 results